Wednesday, April 24, 2019 3:08:12 AM
It should break 26.50 if that holds 28.50 is new high and where old resistance lies.
Duobrii is LONG overdue. Nothing 'soon' about it. No news on it creates uncertainty and why we don't leave 25's behind for good. If one buys once it hits 22 and sells when it hits 26 one could just trade this puppy all year long.
At some point it will break out and head to a new trading range (hopefully in 30's but we'll see)or overall market correction and GS gets their target and it becomes buy 15 sell 18
Duobrii is LONG overdue. Nothing 'soon' about it. No news on it creates uncertainty and why we don't leave 25's behind for good. If one buys once it hits 22 and sells when it hits 26 one could just trade this puppy all year long.
At some point it will break out and head to a new trading range (hopefully in 30's but we'll see)or overall market correction and GS gets their target and it becomes buy 15 sell 18
Recent BHC News
- Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China • PR Newswire (US) • 05/28/2026 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:02:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:57:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:30:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:25:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:19:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:14:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:10:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 09:41:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 09:16:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 08:18:10 PM
- Bausch Health Announces 2026 Annual Meeting of Shareholder Results • PR Newswire (US) • 05/19/2026 08:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 01:42:39 PM
- Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference • PR Newswire (Canada) • 05/13/2026 11:00:00 AM
- Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference • PR Newswire (US) • 05/13/2026 11:00:00 AM
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference • PR Newswire (Canada) • 05/12/2026 08:15:00 PM
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference • PR Newswire (US) • 05/12/2026 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 08:10:14 PM
- BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS • PR Newswire (Canada) • 04/29/2026 08:05:00 PM
- BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS • PR Newswire (US) • 04/29/2026 08:05:00 PM
- Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering • PR Newswire (US) • 04/14/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/08/2026 08:07:14 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/08/2026 08:06:22 PM
